In:
International Journal of Cancer, Wiley, Vol. 138, No. 3 ( 2016-02), p. 576-583
Abstract:
What's new? Non‐alcoholic fatty liver disease (NAFLD) is associated with an increased risk of colorectal cancer (CRC), potentially warranting earlier colorectal screening for NAFLD patients. It remains unclear, however, which of the existing CRC screening options would most benefit this population. In the present evaluation of the cost‐effectiveness of different CRC screening strategies, colonoscopy performed once every 10 years starting at age 50 was determined to be economically superior for patients with NAFLD and for persons with a family history of CRC. Annual fecal immunochemical testing was the most cost‐effective approach for individuals without a family history of CRC.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8